explore -WSS

explore

author：leisure time 2025-09-06 03:28:27 - browse：9

Three boxes of Wegovy stands in a line — coverage from STAT — Steffen Trumpf/picture alliance/Getty Images

WASHINGTON — Novo Nordisk’s newly won permission to market the heart benefits of its obesity drug Wegovy could provide a backdoor way to expand access to the drug for people on Medicare, experts told STAT.

Currently, Medicare is prohibited by law from covering medications for obesity treatment alone. While companies that manufacture wildly popular anti-obesity medications and their allies haven’t been successful in lobbying Congress to change the law, the Food and Drug Administration’s move could give doctors an avenue to prescribe the medications to some Medicare patients.

Wegovy’s new label indicates that the drug can be used to reduce the risk of major heart complications for people who are overweight or obese and have existing heart disease, Novo said in a statement Friday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Guardant Health colon cancer test endorsed by FDA advisory panel

WSS

Medical students need to learn the potent medicine of empathy

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Guardant Health colon cancer test endorsed by FDA advisory panel

Beyond aggravation: Constipation is an American epidemic

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

FDA does about

focus

explore

entertainment

What does generative AI mean for health care? We asked experts

Congress gives doctors Medicare pay bump

In Memoriam: Notable people who died in 2023

The Bio Revolution is changing business and society

At least 13 dead in Texas as scorching temps continue

Why we need mandatory labeling of GMO products

As demand for Covid shots wanes, Moderna seeks its next success

Flu vaccine offering decent levels of protection this winter, new data show

Anesthesiologist group: stop taking Ozempic before surgery

Some medical students still think black patients feel less pain

explore

Louisiana bill approved classifying abortion pills as controlled substances

Obesity now affects over 1 billion people worldwide, study finds

Why some fertility treatments produce more boy babies

Louisiana bill approved classifying abortion pills as controlled substances

Decentralized clinical trials need collaboration to achieve wider use

J&J reports mixed data on next

leisure time

entertainment

Wikipedia

hotspot